How To Read a Network Meta-analysis.
Network meta-analysis (NMA) expands upon traditional meta-analysis by integrating three or more interventions. This allows comparing interventions using evidence from trials that have compared pairs o...
Pneumopathie infectieuse sous ventilation assistée : Questions médicales fréquentes
Questions fréquentes et termes MeSH associés
Diagnostic 5
#1
Comment diagnostiquer une pneumonie associée à la ventilation ?
Le diagnostic repose sur des examens cliniques, radiologiques et microbiologiques.
#2
Quels examens sont recommandés pour le diagnostic ?
Une radiographie thoracique et des cultures de sécrétions bronchiques sont essentielles.
#3
Quels signes cliniques indiquent une pneumonie ?
Fièvre, toux, dyspnée et production de crachats purulents sont des signes clés.
#4
Quelle est l'importance des biomarqueurs ?
Les biomarqueurs comme la procalcitonine aident à évaluer la gravité de l'infection.
#5
Comment évaluer la gravité de la pneumonie ?
L'évaluation clinique et les scores de gravité comme le CURB-65 sont utilisés.
Symptômes 5
#1
Quels sont les symptômes courants de cette pneumonie ?
Les symptômes incluent fièvre, toux, dyspnée et douleur thoracique.
#2
La production de crachats est-elle fréquente ?
Oui, la production de crachats purulents est un symptôme fréquent.
#3
Peut-on avoir des symptômes systémiques ?
Oui, des symptômes comme fatigue et malaise général peuvent survenir.
#4
Les symptômes varient-ils selon l'âge ?
Oui, les symptômes peuvent être plus discrets chez les personnes âgées.
#5
Comment la ventilation affecte-t-elle les symptômes ?
La ventilation peut masquer certains symptômes, rendant le diagnostic plus difficile.
Prévention 5
#1
Quelles mesures préventives sont recommandées ?
L'hygiène des mains, l'élévation de la tête du lit et la désinfection des équipements sont cruciales.
#2
Comment l'élévation de la tête du lit aide-t-elle ?
Elle réduit le risque d'aspiration et améliore la ventilation pulmonaire.
#3
Les vaccins sont-ils utiles ?
Oui, les vaccins contre la grippe et le pneumocoque peuvent réduire le risque.
#4
Quel rôle joue la formation du personnel médical ?
La formation aide à appliquer les protocoles de prévention des infections efficacement.
#5
Comment surveiller les patients sous ventilation ?
Une surveillance régulière des signes vitaux et des sécrétions est essentielle.
Traitements 5
#1
Quel est le traitement de première ligne ?
Les antibiotiques à large spectre sont généralement le traitement initial.
#2
Quand utiliser des antibiotiques spécifiques ?
Les antibiotiques spécifiques sont utilisés après identification de l'agent pathogène.
#3
Des traitements adjuvants sont-ils nécessaires ?
Oui, des traitements comme la kinésithérapie respiratoire peuvent être bénéfiques.
#4
Comment gérer les complications respiratoires ?
La gestion inclut le soutien respiratoire et la surveillance étroite des patients.
#5
Quelle est l'importance de la désintubation précoce ?
La désintubation précoce peut réduire le risque de pneumonie associée à la ventilation.
Complications 5
#1
Quelles complications peuvent survenir ?
Les complications incluent l'insuffisance respiratoire, l'abcès pulmonaire et la septicémie.
#2
Comment prévenir les complications ?
Une surveillance étroite et un traitement précoce des infections sont essentiels.
#3
Les complications augmentent-elles la mortalité ?
Oui, les complications peuvent significativement augmenter le risque de mortalité.
#4
Quel est l'impact de la durée de ventilation ?
Une ventilation prolongée augmente le risque de pneumonie et de complications.
#5
Comment gérer une septicémie liée à la pneumonie ?
Le traitement inclut des antibiotiques appropriés et un soutien hémodynamique.
Facteurs de risque 5
#1
Quels sont les principaux facteurs de risque ?
Les facteurs incluent l'âge avancé, les comorbidités et la durée de ventilation.
#2
Le tabagisme influence-t-il le risque ?
Oui, le tabagisme augmente le risque de pneumonie et de complications respiratoires.
#3
Les patients immunodéprimés sont-ils plus à risque ?
Oui, les patients immunodéprimés présentent un risque accru d'infections pulmonaires.
#4
Comment l'alimentation affecte-t-elle le risque ?
Une mauvaise nutrition peut affaiblir le système immunitaire et augmenter le risque.
#5
Les antécédents de pneumonie augmentent-ils le risque ?
Oui, des antécédents de pneumonie augmentent le risque de récidive sous ventilation.
Contenu validé par Dr Olivier Menir
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 10/05/2025
Contenu vérifié selon les dernières recommandations médicales
Auteurs principaux
None None
6 publications dans cette catégorie
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Ventilator-associated pneumonia: The central role of transcolonization.
Journal of critical care 2018-12-06
-
Nebulized Antibiotics for Healthcare- and Ventilator-Associated Pneumonia.
Seminars in respiratory and critical care medicine 2022-01-18
-
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.
The New England journal of medicine 2023-10-25
-
Accuracy of the clinical pulmonary infection score to differentiate ventilator-associated tracheobronchitis from ventilator-associated pneumonia.
Annals of intensive care 2020-08-03
-
Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest.
The New England journal of medicine
Michael Klompas
5 publications dans cette catégorie
Affiliations :
- Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, USA.
- Department of Medicine, Brigham and Women's Hospital, Boston, USA.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Ventilator-associated pneumonia in adults: a narrative review.
Intensive care medicine 2020-03-10
-
Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update.
Infection control and hospital epidemiology 2022-05-20
-
Ventilator-Associated Pneumonia, Ventilator-Associated Events, and Nosocomial Respiratory Viral Infections on the Leeside of the Pandemic.
Respiratory care 2024-05-28
-
New Insights into the Prevention of Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Caused by Viruses.
Seminars in respiratory and critical care medicine 2022-01-18
-
Temporal trends in postoperative and ventilator-associated pneumonia in the United States.
Infection control and hospital epidemiology 2022-11-03
Marin H Kollef
3 publications dans cette catégorie
Affiliations :
- Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.
Critical care explorations 2023-02-24
-
Is Zero Ventilator-Associated Pneumonia Achievable? Updated Practical Approaches to Ventilator-Associated Pneumonia Prevention.
Infectious disease clinics of North America 2023-11-30
-
The importance of viruses in ventilator-associated pneumonia.
Infection control and hospital epidemiology 2022-09-29
Saad Nseir
3 publications dans cette catégorie
Affiliations :
- CHU de Lille, Médecine Intensive-Réanimation, Lille, France.
- Inserm U1285, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, Lille, France.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia and Ventilator-Associated Tracheobronchitis in COVID-19.
Seminars in respiratory and critical care medicine 2022-01-18
-
Ventilator-Associated Pneumonia in Immunosuppressed Patients.
Antibiotics (Basel, Switzerland) 2023-02-20
-
Accuracy of the clinical pulmonary infection score to differentiate ventilator-associated tracheobronchitis from ventilator-associated pneumonia.
Annals of intensive care 2020-08-03
Ignacio Martin-Loeches
3 publications dans cette catégorie
Affiliations :
- Network Centre for Biomedical Research in Respiratory Diseases (CibeRes, CB06/06/0028), Carlos III Health Institute, 28029 Madrid, Spain.
- St. James's Hospital, Multidisciplinary Intensive Care Research Organization (MICRO), Dublin D03 VX82, Ireland.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Ventilator-Associated Pneumonia and PaO
Journal of clinical medicine 2019-08-14
-
Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
European respiratory review : an official journal of the European Respiratory Society 2020-08-04
-
Accuracy of the clinical pulmonary infection score to differentiate ventilator-associated tracheobronchitis from ventilator-associated pneumonia.
Annals of intensive care 2020-08-03
Antoni Torres
3 publications dans cette catégorie
Affiliations :
- Department of Pneumology, Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute - IDIBAPS, University of Barcelona, 08036 Barcelona, Spain. atorres@ub.edu.
- Network Centre for Biomedical Research in Respiratory Diseases (CibeRes, CB06/06/0028), Carlos III Health Institute, 28029 Madrid, Spain. atorres@ub.edu.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Ventilator-Associated Pneumonia and PaO
Journal of clinical medicine 2019-08-14
-
Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
European respiratory review : an official journal of the European Respiratory Society 2020-08-04
-
Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia.
Seminars in respiratory and critical care medicine 2022-01-27
Scott T Micek
2 publications dans cette catégorie
Affiliations :
- Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, MO.
- Department of Pharmacy Practice, University of Health Sciences and Pharmacy, St. Louis, MO.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.
Critical care explorations 2023-02-24
-
The importance of viruses in ventilator-associated pneumonia.
Infection control and hospital epidemiology 2022-09-29
Charles-Edouard Luyt
2 publications dans cette catégorie
Affiliations :
- Service de Médecine Intensive Réanimation, Sorbonne Université, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris.
- INSERM UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Paris.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia.
Seminars in respiratory and critical care medicine 2022-01-31
-
Ventilator-associated pneumonia in adults: a narrative review.
Intensive care medicine 2020-03-10
Mark L Metersky
2 publications dans cette catégorie
Affiliations :
- Division of Pulmonary, Critical Care and Sleep Medicine, University of Connecticut School of Medicine, UConn Health, 263 Farmington Avenue, Farmington, CT 06030-1321, USA. Electronic address: Metersky@uchc.edu.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Management of Ventilator-Associated Pneumonia: Guidelines.
Infectious disease clinics of North America
-
Temporal trends in postoperative and ventilator-associated pneumonia in the United States.
Infection control and hospital epidemiology 2022-11-03
Alexandre Gaudet
2 publications dans cette catégorie
Affiliations :
- Médecine Intensive Réanimation, CHU de Lille, F-59000 Lille, France.
- Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d'Infection et d'Immunité de Lille, F-59000 Lille, France.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Ventilator-Associated Pneumonia in Immunosuppressed Patients.
Antibiotics (Basel, Switzerland) 2023-02-20
-
Accuracy of the clinical pulmonary infection score to differentiate ventilator-associated tracheobronchitis from ventilator-associated pneumonia.
Annals of intensive care 2020-08-03
Jean-Pierre Quenot
2 publications dans cette catégorie
Affiliations :
- From Centre Hospitalier Régional Universitaire (CHRU) de Tours, Médecine Intensive Réanimation, INSERM Centre d'Investigation Clinique (CIC) 1415, Clinical Research in Intensive Care and Sepsis-Trial Group for Global Evaluation and Research in Sepsis (CRICS_TRIGGERSep) French Clinical Research Infrastructure Network (F-CRIN) Research Network (S.E., E.M., D.G., C.S.G.), INSERM, Research Center for Respiratory Diseases (S.E., F.B., N.H.-V., R.R.), the University of Tours (S.E., N.H.-V., R.R.), CHRU de Tours, Réanimation Chirurgicale (M.F.), CHRU de Tours, Pharmacie (R.R.), and CHRU de Tours, INSERM CIC 1415 and Université de Tours et Nantes, Methods in Patient-Centered Outcomes and Health Research, INSERM 1246 (E.T.), Tours, Centre Hospitalier et Universitaire (CHU) d'Orléans, Médecine Intensive Réanimation, Orléans (F.B., M.-A.N., D.B.), Médecine Intensive-Réanimation, Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil and INSERM, Unité Mixte de Recherche (UMR) 1260, Regenerative Nanomedicine, Université de Strasbourg, Faculté de Médecine, Fédération de Médecine Translationnelle de Strasbourg (J.D., F.M., H.M.), and Hôpitaux Universitaires de Strasbourg, Hôpital Hautepierre, Médecine Intensive Réanimation (J.-E.H., R.C.-J.), Strasbourg, the Department of Intensive Care, Burgundy University Hospital and Lipness Team, INSERM Research Center Lipids, Nutrition, Cancer (LNC)-UMR1231 and LabEx LipSTIC, University of Burgundy, and INSERM CIC 1432, Clinical Epidemiology, University of Burgundy (J.-P.Q.), and the Department of Intensive Care, Burgundy University Hospital (P.A.), Dijon, Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Louis Mourier, Départements Médico-Universitaires Enseignements et Soins de Proximité, Recherche, Innovation et Territoires (DMU ESPRIT), Service de Médecine Intensive Réanimation, Colombes (D.R., N.Z.), INSERM/French National Center for Scientific Research, Institut Necker Enfants Malades, Université Paris Cité (D.R.), and Multidisciplinary Intensive Care Unit, Department of Anesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University (Q.L.), Paris, Centre Hospitalier Départemental Vendée, Médecine Intensive Réanimation, La Roche sur Yon (J.-C.L., M.-A.A.), Centre Hospitalier (CH) du Mans, Médecine Intensive Réanimation, Le Mans (M.L., M.S.-M.), CHU de Rennes, Réanimation Chirurgicale, Rennes (P.S.), CH Angoulême, Médecine Intensive Réanimation, Angoulême (D.S.), CHU de Poitiers, Médecine Intensive Réanimation (A.V.), Université de Poitiers, INSERM, Pharmacologie des Anti-Infectieux et Antibiorésistance (PHAR2), Unité 1070 and CHU de Poitiers, Anesthésie-Réanimation-Médecine Péri-Opératoire, F-86000 (C.D.-F.), Université de Poitiers, PHAR2 INSERM U1070 (N.G.), and CHU de Poitiers, Service de Toxicologie et Pharmacologie (N.G.). Poitiers, CHU de Rouen, Réanimation Chirurgicale (P.G.), University Rouen Normandie, Normandie University, Groupe de Recherche sur le Handicap Ventilatoire et Neurologique, Unité de recherche 3830 and Intensive Care Medicine, Rouen University Hospital (G.B.), Rouen, CHU Angers, Réanimation Chirurgicale, Angers (S.L.), CH d'Argenteuil, Réanimation Polyvalente, Argenteuil (G.P.), and Réanimation Médicale, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon (N.C.) - all in France; and the Department of Emergency Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China (Q.L.).
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.
The New England journal of medicine 2023-10-25
-
Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest.
The New England journal of medicine
Gaëtan Plantefève
2 publications dans cette catégorie
Affiliations :
- From Centre Hospitalier Régional Universitaire (CHRU) de Tours, Médecine Intensive Réanimation, INSERM Centre d'Investigation Clinique (CIC) 1415, Clinical Research in Intensive Care and Sepsis-Trial Group for Global Evaluation and Research in Sepsis (CRICS_TRIGGERSep) French Clinical Research Infrastructure Network (F-CRIN) Research Network (S.E., E.M., D.G., C.S.G.), INSERM, Research Center for Respiratory Diseases (S.E., F.B., N.H.-V., R.R.), the University of Tours (S.E., N.H.-V., R.R.), CHRU de Tours, Réanimation Chirurgicale (M.F.), CHRU de Tours, Pharmacie (R.R.), and CHRU de Tours, INSERM CIC 1415 and Université de Tours et Nantes, Methods in Patient-Centered Outcomes and Health Research, INSERM 1246 (E.T.), Tours, Centre Hospitalier et Universitaire (CHU) d'Orléans, Médecine Intensive Réanimation, Orléans (F.B., M.-A.N., D.B.), Médecine Intensive-Réanimation, Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil and INSERM, Unité Mixte de Recherche (UMR) 1260, Regenerative Nanomedicine, Université de Strasbourg, Faculté de Médecine, Fédération de Médecine Translationnelle de Strasbourg (J.D., F.M., H.M.), and Hôpitaux Universitaires de Strasbourg, Hôpital Hautepierre, Médecine Intensive Réanimation (J.-E.H., R.C.-J.), Strasbourg, the Department of Intensive Care, Burgundy University Hospital and Lipness Team, INSERM Research Center Lipids, Nutrition, Cancer (LNC)-UMR1231 and LabEx LipSTIC, University of Burgundy, and INSERM CIC 1432, Clinical Epidemiology, University of Burgundy (J.-P.Q.), and the Department of Intensive Care, Burgundy University Hospital (P.A.), Dijon, Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Louis Mourier, Départements Médico-Universitaires Enseignements et Soins de Proximité, Recherche, Innovation et Territoires (DMU ESPRIT), Service de Médecine Intensive Réanimation, Colombes (D.R., N.Z.), INSERM/French National Center for Scientific Research, Institut Necker Enfants Malades, Université Paris Cité (D.R.), and Multidisciplinary Intensive Care Unit, Department of Anesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University (Q.L.), Paris, Centre Hospitalier Départemental Vendée, Médecine Intensive Réanimation, La Roche sur Yon (J.-C.L., M.-A.A.), Centre Hospitalier (CH) du Mans, Médecine Intensive Réanimation, Le Mans (M.L., M.S.-M.), CHU de Rennes, Réanimation Chirurgicale, Rennes (P.S.), CH Angoulême, Médecine Intensive Réanimation, Angoulême (D.S.), CHU de Poitiers, Médecine Intensive Réanimation (A.V.), Université de Poitiers, INSERM, Pharmacologie des Anti-Infectieux et Antibiorésistance (PHAR2), Unité 1070 and CHU de Poitiers, Anesthésie-Réanimation-Médecine Péri-Opératoire, F-86000 (C.D.-F.), Université de Poitiers, PHAR2 INSERM U1070 (N.G.), and CHU de Poitiers, Service de Toxicologie et Pharmacologie (N.G.). Poitiers, CHU de Rouen, Réanimation Chirurgicale (P.G.), University Rouen Normandie, Normandie University, Groupe de Recherche sur le Handicap Ventilatoire et Neurologique, Unité de recherche 3830 and Intensive Care Medicine, Rouen University Hospital (G.B.), Rouen, CHU Angers, Réanimation Chirurgicale, Angers (S.L.), CH d'Argenteuil, Réanimation Polyvalente, Argenteuil (G.P.), and Réanimation Médicale, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon (N.C.) - all in France; and the Department of Emergency Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China (Q.L.).
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.
The New England journal of medicine 2023-10-25
-
Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest.
The New England journal of medicine
Raphaël Clere-Jehl
2 publications dans cette catégorie
Affiliations :
- From Centre Hospitalier Régional Universitaire (CHRU) de Tours, Médecine Intensive Réanimation, INSERM Centre d'Investigation Clinique (CIC) 1415, Clinical Research in Intensive Care and Sepsis-Trial Group for Global Evaluation and Research in Sepsis (CRICS_TRIGGERSep) French Clinical Research Infrastructure Network (F-CRIN) Research Network (S.E., E.M., D.G., C.S.G.), INSERM, Research Center for Respiratory Diseases (S.E., F.B., N.H.-V., R.R.), the University of Tours (S.E., N.H.-V., R.R.), CHRU de Tours, Réanimation Chirurgicale (M.F.), CHRU de Tours, Pharmacie (R.R.), and CHRU de Tours, INSERM CIC 1415 and Université de Tours et Nantes, Methods in Patient-Centered Outcomes and Health Research, INSERM 1246 (E.T.), Tours, Centre Hospitalier et Universitaire (CHU) d'Orléans, Médecine Intensive Réanimation, Orléans (F.B., M.-A.N., D.B.), Médecine Intensive-Réanimation, Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil and INSERM, Unité Mixte de Recherche (UMR) 1260, Regenerative Nanomedicine, Université de Strasbourg, Faculté de Médecine, Fédération de Médecine Translationnelle de Strasbourg (J.D., F.M., H.M.), and Hôpitaux Universitaires de Strasbourg, Hôpital Hautepierre, Médecine Intensive Réanimation (J.-E.H., R.C.-J.), Strasbourg, the Department of Intensive Care, Burgundy University Hospital and Lipness Team, INSERM Research Center Lipids, Nutrition, Cancer (LNC)-UMR1231 and LabEx LipSTIC, University of Burgundy, and INSERM CIC 1432, Clinical Epidemiology, University of Burgundy (J.-P.Q.), and the Department of Intensive Care, Burgundy University Hospital (P.A.), Dijon, Université Paris Cité, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Louis Mourier, Départements Médico-Universitaires Enseignements et Soins de Proximité, Recherche, Innovation et Territoires (DMU ESPRIT), Service de Médecine Intensive Réanimation, Colombes (D.R., N.Z.), INSERM/French National Center for Scientific Research, Institut Necker Enfants Malades, Université Paris Cité (D.R.), and Multidisciplinary Intensive Care Unit, Department of Anesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University (Q.L.), Paris, Centre Hospitalier Départemental Vendée, Médecine Intensive Réanimation, La Roche sur Yon (J.-C.L., M.-A.A.), Centre Hospitalier (CH) du Mans, Médecine Intensive Réanimation, Le Mans (M.L., M.S.-M.), CHU de Rennes, Réanimation Chirurgicale, Rennes (P.S.), CH Angoulême, Médecine Intensive Réanimation, Angoulême (D.S.), CHU de Poitiers, Médecine Intensive Réanimation (A.V.), Université de Poitiers, INSERM, Pharmacologie des Anti-Infectieux et Antibiorésistance (PHAR2), Unité 1070 and CHU de Poitiers, Anesthésie-Réanimation-Médecine Péri-Opératoire, F-86000 (C.D.-F.), Université de Poitiers, PHAR2 INSERM U1070 (N.G.), and CHU de Poitiers, Service de Toxicologie et Pharmacologie (N.G.). Poitiers, CHU de Rouen, Réanimation Chirurgicale (P.G.), University Rouen Normandie, Normandie University, Groupe de Recherche sur le Handicap Ventilatoire et Neurologique, Unité de recherche 3830 and Intensive Care Medicine, Rouen University Hospital (G.B.), Rouen, CHU Angers, Réanimation Chirurgicale, Angers (S.L.), CH d'Argenteuil, Réanimation Polyvalente, Argenteuil (G.P.), and Réanimation Médicale, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon (N.C.) - all in France; and the Department of Emergency Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China (Q.L.).
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.
The New England journal of medicine 2023-10-25
-
Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest.
The New England journal of medicine
Linda R Greene
2 publications dans cette catégorie
Affiliations :
- Highland Hospital, University of Rochester, Rochester, New York.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update.
Infection control and hospital epidemiology 2022-05-20
-
Non-ventilator health care-associated pneumonia (NV-HAP).
American journal of infection control
Andrew Conway Morris
2 publications dans cette catégorie
Affiliations :
- JVF Intensive Care Unit, Addenbrooke's Hospital, Cambridge, United Kingdom.
- Department of Medicine, Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias.
Seminars in respiratory and critical care medicine 2022-01-18
-
Ventilator-associated pneumonia in critically ill patients with COVID-19.
Critical care (London, England) 2021-01-11
Hayley Motowski
1 publication dans cette catégorie
Affiliations :
- Department of Medical Education, Washington University School of Medicine, St. Louis, MO.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.
Critical care explorations 2023-02-24
Daniel Ilges
1 publication dans cette catégorie
Affiliations :
- Depatment of Pharmacy, Mayo Clinic Hospital, Phoenix, AZ.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.
Critical care explorations 2023-02-24
Nicholas Hampton
1 publication dans cette catégorie
Affiliations :
- Center for Clinical Excellence, BJC HealthCare, St. Louis, MO.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.
Critical care explorations 2023-02-24
Anahita Rouzé
1 publication dans cette catégorie
Affiliations :
- CHU de Lille, Médecine Intensive-Réanimation, Lille, France.
- Inserm U1285, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, Lille, France.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia and Ventilator-Associated Tracheobronchitis in COVID-19.
Seminars in respiratory and critical care medicine 2022-01-18
Norma B Fernandez
1 publication dans cette catégorie
Affiliations :
- Sección Micología, División Infectología, Hospital de Clínicas "José de San Martin", Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Publications dans "Pneumopathie infectieuse sous ventilation assistée" :
-
Ventilator-associated pneumonia involving
Medical mycology case reports 2020-07-05
Sources (10000 au total)
Methodological quality of network meta-analysis in dentistry: a meta-research.
This meta-research aimed to provide an overview of the methodological quality and risk of bias of network meta-analyses (NMA) in dentistry. Searches for NMA of randomized clinical trials with clinical...
Effects of non-pharmacological interventions for adults with subjective cognitive decline: a network meta-analysis and component network meta-analysis.
Non-pharmacological interventions have a myriad of available intervention options and contain multiple components. Whether specific components of non-pharmacological interventions or combinations are ... PubMed, Embase, Cochrane, CINAHL, PsycINFO, CENTRAL, Web of Science, and China's two largest databases, CNKI and Wanfang, were searched from inception to 22nd, January 2023. Randomized controlled tria... A total of 39 trials with 2959 patients were included (range of mean ages, 58.79-77.41 years). Resistance exercise might be the optimal intervention for reducing memory complaints in adults with subje... The form of physical activity performed appears to be more beneficial than cognitive interventions in reducing subjective memory complaints for adults with subjective cognitive decline, and this diffe... PROSPERO registry number. CRD42022355363....
Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analyses.
Effect modification (EM) may cause bias in network meta-analysis (NMA). Existing population adjustment NMA methods use individual patient data to adjust for EM but disregard available subgroup informa...
Treatments for alopecia areata: a network meta-analysis.
Alopecia areata is an autoimmune disease leading to nonscarring hair loss on the scalp or body. There are different treatments including immunosuppressants, hair growth stimulants, and contact immunot... To assess the benefits and harms of the treatments for alopecia areata (AA), alopecia totalis (AT), and alopecia universalis (AU) in children and adults.... The Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase, ClinicalTrials.gov and WHO ICTRP were searched up to July 2022.... We included randomised controlled trials (RCTs) that evaluated classical immunosuppressants, biologics, small molecule inhibitors, contact immunotherapy, hair growth stimulants, and other therapies in... We used the standard procedures expected by Cochrane including assessment of risks of bias using RoB2 and the certainty of the evidence using GRADE. The primary outcomes were short-term hair regrowth ... We included 63 studies that tested 47 different treatments in 4817 randomised participants. All trials used a parallel-group design except one that used a cross-over design. The mean sample size was 7... We found that treatment with baricitinib results in an increase in short- and long-term hair regrowth compared to placebo. Although we found inconclusive results for the risk of serious adverse effect...
Bias propagation in network meta-analysis models.
Network meta-analysis combines direct and indirect evidence to compare multiple treatments. As direct evidence for one treatment contrast may be indirect evidence for other treatment contrasts, biases...
Does type of funding affect reporting in network meta-analysis? A scoping review of network meta-analyses.
Evidence has shown that private industry-sponsored randomized controlled trials (RCTs) and meta-analyses are more likely to report intervention-favourable results compared with other sources of fundin... To (a) explore the recommendation rate of industry-sponsored NMAs on their company's intervention, and (b) assess reporting in NMAs of pharmacologic interventions according to their funding type.... Design: Scoping review of published NMAs with RCTs.... We used a pre-existing NMA database including 1,144 articles from MEDLINE, EMBASE and Cochrane Database of Systematic Reviews, published between January 2013 and July 2018.... NMAs with transparent funding information and comparing pharmacologic interventions with/without placebo.... We captured whether NMAs recommended their own or another company's intervention, classified NMAs according to their primary outcome findings (i.e., statistical significance and direction of effect), ... We retrieved 658 NMAs, which reported a median of 23 items in the PRISMA-NMA checklist (interquartile range [IQR]: 21-26). NMAs were categorized as 314 publicly-sponsored (PRISMA-NMA median 24.5, IQR ... Differences in completeness of reporting and author characteristics were apparent among NMAs with different types of funding. Publicly-sponsored NMAs had the best reporting and published their finding...
Efficacy of innovative therapies in myasthenia gravis: A systematic review, meta-analysis and network meta-analysis.
Therapy for myasthenia gravis (MG) is undergoing a profound change, with new treatments being tested. These include complement inhibitors and neonatal Fc receptor (FcRn) blockers. The aim of this stud... We assessed statistical heterogeneity across trials based on the Cochrane Q test and I... We observed an overall mean Myasthenia Gravis-Activities of Daily Living scale (MG-ADL) score change of -2.17 points (95% confidence interval [CI] -2.67, -1.67; p < 0.001) as compared to placebo. No s... Anti-complement and FcRn treatments both proved to be effective in MG patients, whereas rituximab did not show a significant benefit for patients. Within the limitations of this meta-analysis, includi...
Effectiveness of aerobic exercise in the prevention and treatment of postpartum depression: Meta-analysis and network meta-analysis.
Aerobic exercise is widely recognized for improving mental health and reducing negative emotions, including anxiety. However, research on its role in preventing and treating postpartum depression (PPD... We conducted a quantitative systematic review of the study in 5 representative databases for the effect of aerobic exercise on PPD. Meta-analysis and network meta-analysis were performed with Review-M... Twenty-six studies with 2,867 participants were eventually included and the efficacy of aerobic exercise in preventing and treating postpartum depression is significant compared to standard care. (MD ... The efficacy of aerobic exercise in preventing and treating postpartum depression is significant compared to standard care, with a greater emphasis on prevention. The optimal prescribed exercise volum...
Antibiotic Prophylaxis in Reduction Mammaplasty: A Network Meta-Analysis.
Mounting evidence suggests that breast reduction surgery displays higher rates of surgical site infections (SSI) than initially presumed. Objective of this network meta-analysis is to evaluate the eff... A network meta-analysis was conducted using a predetermined protocol after searching the electronic databases MEDLINE, Scopus, the Cochrane Library and US National Institutes of Health Ongoing Trials ... A total of 10 studies was included in the analysis involving 1331 patients. All but one study controlled for major risk factors, and no differences were observed in patients' baseline characteristics.... Antibiotics mitigate the SSI rate after breast reduction. This meta-analysis provides an evidence-based strategy to optimize antibiotic administration. Further research is needed though to examine ant... This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Inst...